摘要:一枚从阿斯利康研发体系飞出的药物分子,历经九年本土打磨,最终以超15亿美元的总交易对价重回老东家怀抱。
特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布,本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.